Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Mitchell

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Cancer Treatment Reports|September 1, 1985
Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinomaS M Grunberg, R A Kempf, L M Itri, et al.
Genomics|July 1, 1994
Assignment of a human melanoma associated gene MG50 (D2S448) to chromosome 2p25.3 by fluorescence in situ hybridizationS R Weiler, S M Taylor, R J Deans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected]M S Mitchell, R A Kempf, W Harel, et al.
Cancer Research|October 1, 1990
Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitroW Harel, H Shau, C G Hadley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-mW D Quan, G E Dean, L Spears, et al.
International Journal of Cancer|June 17, 1998
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptideM Reddish, G D MacLean, R R Koganty, et al.
Blood|September 1, 1986
Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlationJ H Bertram, P S Gill, A M Levine, et al.
Cancer Research|November 1, 1986
Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trialR A Matthay, D A Mahler, G J Beck, et al.
Annals of the New York Academy of Sciences|August 12, 1993
Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of actionM S Mitchell, W Harel, J Kan-Mitchell, et al.
Journal of Negative Results in Biomedicine|November 28, 2006
A study of association between common variation in the growth hormone-chorionic somatomammotropin hormone gene cluster and adult fasting insulin in a UK Caucasian populationRachel M Freathy, Simon M S Mitchell, Beatrice Knight, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Cancer Treatment Reports|September 1, 1985
Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinomaS M Grunberg, R A Kempf, L M Itri, et al.
Genomics|July 1, 1994
Assignment of a human melanoma associated gene MG50 (D2S448) to chromosome 2p25.3 by fluorescence in situ hybridizationS R Weiler, S M Taylor, R J Deans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected]M S Mitchell, R A Kempf, W Harel, et al.
Cancer Research|October 1, 1990
Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitroW Harel, H Shau, C G Hadley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-mW D Quan, G E Dean, L Spears, et al.
International Journal of Cancer|June 17, 1998
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptideM Reddish, G D MacLean, R R Koganty, et al.
Blood|September 1, 1986
Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlationJ H Bertram, P S Gill, A M Levine, et al.
Cancer Research|November 1, 1986
Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trialR A Matthay, D A Mahler, G J Beck, et al.
Annals of the New York Academy of Sciences|August 12, 1993
Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of actionM S Mitchell, W Harel, J Kan-Mitchell, et al.
Journal of Negative Results in Biomedicine|November 28, 2006
A study of association between common variation in the growth hormone-chorionic somatomammotropin hormone gene cluster and adult fasting insulin in a UK Caucasian populationRachel M Freathy, Simon M S Mitchell, Beatrice Knight, et al.
Pageof 18